Literature DB >> 6837595

Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1.

K S Hershon, W A Kelly, C M Shaw, R Schwartz, E L Bierman.   

Abstract

The pituitary tumors seen in the multiple endocrine neoplastic syndrome type 1 have generally been considered "nonfunctional." Fewer than 40 persons with hyperprolactinemia as part of the syndrome have been described. A family with the largest number of subjects (six) with prolactinomas in one generation reported to date is described. The variable aggressiveness of this disease, the difficulty in treatment because of multiple prolactinomas or hyperplasia or both, and a case of tumor shrinkage with bromocriptine therapy are also demonstrated in this unique family.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837595     DOI: 10.1016/0002-9343(83)91032-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

Review 1.  Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation.

Authors:  C Kong; S Ellard; C Johnston; N R Farid
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

2.  Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome.

Authors:  A Morelli; A Falchetti; R Castello; L Furlani; P Tomassetti; F Tonelli; A Frilling; M Serio; M L Brandi
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

3.  Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.

Authors:  E M Petty; J S Green; S J Marx; R T Taggart; N Farid; A E Bale
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.